Home › Funds › Artia Global Partners LP › CYTK
Artia Global Partners LP position in CYTK
CYTOKINETICS INC · Health Care
Artia Global Partners LP reported holding 70,700 shares of CYTK (CYTOKINETICS INC) in its Q2 2026 13F filing — a position valued at US$6.0M, representing 1.11% of its reported portfolio and ranking #19 among its reported holdings. Artia Global Partners LP has disclosed CYTK holdings in 4 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's CYTK position evolved
Artia Global Partners LP first disclosed a stake in CYTK in Q4 2023 at 32,113 shares (US$2.7M). The position peaked in Q1 2024 at 89,525 shares, worth US$6.3M. Across 4 filings, Artia Global Partners LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 70,700 shares valued at US$6.0M — an increase of 54,400 shares quarter over quarter.. Notable position changes include a 179% increase in Q1 2024 (shares fell 23% over the following quarter), a 334% increase in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 32.11K | $2.68M | New |
| Q1 2024 | 89.53K | $6.28M | Add |
| Q1 2026 | 16.30K | $1.07M | New |
| Q2 2026 | 70.70K | $6.02M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 5.00M sh · $425.95M · Q2 2026
- RTW INVESTMENTS, LP 2.86M sh · $243.81M · Q2 2026
- Polar Capital Holdings Plc 2.25M sh · $191.99M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $136.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $102.34M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $83.52M · Q2 2026
- GW&K Investment Management, LLC 916.11K sh · $78.04M · Q2 2026
- Melqart Asset Management (UK) Ltd 767.52K sh · $65.39M · Q2 2026
- Siren, L.L.C. 758.95K sh · $64.66M · Q2 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held CYTK?
Artia Global Partners LP has disclosed CYTK holdings in 4 of the last 11 reported quarters, going back to Q4 2023.
What is Artia Global Partners LP's current position in CYTK?
As of Q2 2026, Artia Global Partners LP holds 70.70K shares of CYTK (CYTOKINETICS INC), valued at $6.02M, representing 1.11% of its reported portfolio and ranking #19.
Has Artia Global Partners LP been buying or selling CYTK?
In the latest 13F filing (Q2 2026), Artia Global Partners LP increased its position in CYTK. The position peaked in Q1 2024 at 89.53K shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.